ReviewTherapeutic innovation & regulatory science2022

Global Regulatory and Public Health Initiatives to Advance Pediatric Drug Development for Rare Diseases.

Carla Epps et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.